1Y Close · As of Aug 26, 2026
Aligned Genetics operates in the Medical, Precision & Optical sector.
Legal name: Aligned Genetics, Inc.
In fiscal year 2025, Aligned Genetics (238120) reported revenue of 16.0 billion KRW, up 1.5% from 15.8 billion KRW a year earlier.
Operating profit was 2.4 billion KRW and net income was 2.9 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 42.3 billion KRW, with a P/B of 1.14.
These figures can be verified in the DART filing (receipt no. 20260323001245).
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 1 disposal(s), 1 cancellation(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |